Ezetimibe 10mg
Sponsors
Nakakinen clinic, University of Oxford, Hanmi Pharmaceutical Company Limited, Esperion Therapeutics, Inc., Imperial College London
Conditions
Acute Myocardial InfarctionAtherosclerosisDiabetes Mellitus, Type 2Diabetic Kidney DiseaseDyslipidemiasHealthyHealthy VolunteersHigh Cholesterol
Phase 1
Investigating the Pharmacokinetic Drug Interactions Between Rosuvastatin and Ezetimibe
CompletedNCT02127320
Start: 2014-06-30End: 2014-11-30Updated: 2016-10-12
Study of no Pharmacokinetic Interaction Between Rosuvastatin 20mg and Ezetimibe10mg, Fixed Dose vs Individual Components
CompletedNCT04895059
Start: 2017-04-30End: 2018-01-22Updated: 2021-08-24
A Study to Evaluate Drug-Drug Interactions of Obicetrapib Tablets and Ezetimibe Tablets in Healthy Adult Subjects
CompletedNCT06547359
Start: 2024-10-01End: 2024-11-12Updated: 2024-11-14
Phase 2
Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) 180mg, Ezetimibe 10mg, and Atorvastatin 20 mg Triplet Therapy in Patients With Elevated LDL-C
CompletedNCT03051100
Start: 2017-01-19End: 2017-07-05Updated: 2020-04-03
Randomized Study of Obicetrapib in Combination With Ezetimibe
CompletedNCT04770389
Start: 2021-02-23End: 2021-06-30Updated: 2024-04-24
Study to Evaluate the Effect of Obicetrapib in Combination With Ezetimibe as an Adjunct to HIS Therapy
CompletedNCT05266586
Start: 2022-03-09End: 2022-09-08Updated: 2024-07-03
Study of HSK31679 in Subjects With Hypercholesterolemia With Nonalcoholic Fatty Liver Disease(NAFLD)
CompletedNCT05795517
Start: 2023-04-26End: 2024-03-01Updated: 2024-04-09
Phase 3
Phase 4
Study of Heart and Renal Protection
CompletedNCT00125593
Start: 2003-06-30End: 2010-08-31Updated: 2012-02-01
Early Alirocumab to Reduce LDL-C in Myocardial Infarction
WithdrawnNCT03750760
Start: 2020-01-31End: 2021-12-31Updated: 2019-06-13
CHOlesterol Lowering and Residual Risk in Type 2 Diabetes
CompletedNCT04369664
Start: 2020-08-12End: 2023-10-19Updated: 2024-10-17
Anti-inflammatory Effects of Simvastatin
TerminatedNCT04638400
Start: 2017-05-01End: 2021-11-01Updated: 2024-11-08
Statin and Bone Health
NCT05613400
Start: 2022-04-13End: 2025-06-30Target: 240Updated: 2022-11-28
Effect of Early Initiation of Evolocumab on Lipid Profiles Changes in Patients With ACS Undergoing PCI
CompletedNCT05661552
Start: 2022-12-01End: 2025-02-05Updated: 2025-03-13
Unknown Phase
The lowering effect of ezetimibe on serum lipids and serum lipoprotein in postprandial hyperlipidemi
Active, not recruitingJPRN-UMIN000013611
Start: 2014-03-08Target: 35Updated: 2025-07-18
Ezetimibe and Orlistat Affect the Intestinal Flora of Hyperlipidemia.
NCT03884127
Start: 2019-04-01End: 2019-09-30Target: 58Updated: 2019-03-21
Ezetimibe Utilization Early After Acute Myocardial Infarction, EzAMI Trial
RecruitingNCT04701242
Start: 2021-03-24End: 2025-12-31Target: 500Updated: 2024-08-21
Investigate the Effect of Ezetimibe, Simvastatin, and Omega 3- Fatty Acids on Dyslipidemia Patients: a Pharmacokinetics Based Study
NCT05080140
Start: 2019-06-01End: 2022-03-20Target: 3Updated: 2021-10-15